Thanks. Yeap, hard for me to envision numbers, but the 3-5x...

Thanks. Yeap, hard for me to envision numbers, but the 3-5x EBITDA guide I'll hang onto that. Just curious now how these translate into revenue and NPAT multiples that people usually pay and therefore working out how accretive it is to earnings. I guess this is the better economic environment to do it anyway....
I'd assume for short term they'd have to make a good acquisition to bolt on accretive EPS, get the stock re-rated over the next year, then perhaps they could use a beefed up share price to issue script to fund further bolt on organic growth? ALl just speculation from my inexperienced POV....

It's been awhile since looking at a <10% free float stock, so not sure the net effect on valuations this will bring. My tightest have always been about 80 something % held by top shareholders, so still a good 15-20% free float, and even then market illiquidity and pricing always seemed undervalued at times (until a takeover was lobbed).